Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Nanopore Technologies Licenses Genetics Research's CRISPR DNA Enrichment Technology

NEW YORK – DNA technology startup Genetics Research said on Tuesday that Oxford Nanopore Technologies has licensed its intellectual property relating to CRISPR-based DNA target enrichment.

Under the non-exclusive agreement, Oxford Nanopore can include the technology, which targets long DNA fragments with specific sequences, in its DNA and RNA nanopore sequencing products.

Financial and other terms of the deal were not disclosed.

Genetics Research, based in Wakefield, Massachusetts, has developed a low-cost sequence-specific technology platform, called Negative Enrichment, that uses CRISPR/Cas9 to enrich DNA fragments from a complex background.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.